Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

HER2 Tests for Tratuzumab Response

NEW YORK (Reuters Health) – HER2 protein and gene expression predict the response of breast cancer patients to adjuvant trastuzumab therapy, but which test provides the best information? Two articles in the August 9th Journal of Clinical Oncology online aim to address this question. “Order protein...

Reuters Health • The Doctor's Channel Daily Newscast

Imiquimod for Anal Pre-Cancer

NEW YORK (Reuters Health) – Rates of clearance of high-grade anal canal intraepithelial neoplasia in men with HIV are improved considerably by topical application of imiquimod cream, a UK team reports in an August 19 online issue of AIDS. Dr. Paul A. Fox with the Chelsea and Westminster Hospital NHS...

Reuters Health • The Doctor's Channel Daily Newscast

Toremifene and ADT-Related Fractures

NEW YORK (Reuters Health) – Men undergoing androgen deprivation therapy for prostate cancer halve their risk of vertebral fractures if they take the selective estrogen receptor modulator toremifene daily, according to the results of a double-blind, placebo-controlled phase III study reported in the October...